Assignee
SUN PHARMACEUTICAL IND INC
US·11 granted patents·19 pending applications·8 citations·filing 2019–2025
Top patents by PatentIndex Score
30 records- 0192US12285432B2Treatment of hair loss disorders with deuterated JAK inhibitorsSUN PHARMACEUTICAL IND INC·Filed 2023·Granted Apr 29, 2025·2 cites·28 claims
- 0288US12065395B2Processes for the preparation of deuterated D-serineSUN PHARMACEUTICAL IND INC·Filed 2020·Granted Aug 20, 2024·2 cites·21 claims
- 0387US2025025467A1Deuterated derivatives of ruxolitinibSUN PHARMACEUTICAL IND INC·Filed 2024·Application pending·0 cites
- 0484US12364699B2Method of treating hair loss disordersSUN PHARMACEUTICAL IND INC·Filed 2024·Granted Jul 22, 2025·1 cites·30 claims
- 0584US12029712B2Deuterated analogs of D-serine and uses thereofSUN PHARMACEUTICAL IND INC·Filed 2020·Granted Jul 9, 2024·1 cites·25 claims
- 0683US12076323B2Treatment of hair loss disorders with deuterated JAK inhibitorsSUN PHARMACEUTICAL IND INC·Filed 2019·Granted Sep 3, 2024·2 cites·29 claims
- 0782US2023355629A1Deuterated derivatives of ruxolitinibSUN PHARMACEUTICAL IND INC·Filed 2022·Application pending·0 cites
- 0882US2025000830A1Deuterated analogs of d-serine and uses thereofSUN PHARMACEUTICAL IND INC·Filed 2024·Application pending·0 cites
- 0981US12296011B2Methods for photodynamic therapySUN PHARMACEUTICAL IND INC·Filed 2023·Granted May 13, 2025·0 cites·6 claims
- 1079US12473252B2Processes for the preparation of deuterated D-serineSUN PHARMACEUTICAL IND INC·Filed 2024·Granted Nov 18, 2025·0 cites·16 claims
- 1177US12290700B2Adjustable illuminator for photodynamic therapy and diagnosisSUN PHARMACEUTICAL IND INC·Filed 2022·Granted May 6, 2025·0 cites·15 claims
- 1276US2025235538A1Methods for photodynamic therapySUN PHARMACEUTICAL IND INC·Filed 2025·Application pending·0 cites
- 1375US2025235715A1Adjustable illuminator for photodynamic therapy and diagnosisSUN PHARMACEUTICAL IND INC·Filed 2025·Application pending·0 cites
- 1475US2024423986A1Treatment of hair loss disorders with deuterated jak inhibitorsSUN PHARMACEUTICAL IND INC·Filed 2024·Application pending·0 cites
- 1574US12247034B1Crystalline form of deuruxolitinib phosphateSUN PHARMACEUTICAL IND INC·Filed 2024·Granted Mar 11, 2025·0 cites·14 claims
- 1670US2025319324A1Adjustable illuminators and methods for photodynamic therapy and diagnosisSUN PHARMACEUTICAL IND INC·Filed 2025·Application pending·0 cites
- 1767US11919907B2Deuterated JAK inhibitor and uses thereofSUN PHARMACEUTICAL IND INC·Filed 2021·Granted Mar 5, 2024·0 cites·24 claims
- 1866US2024300963A1Process for preparing enantiomerically enriched jak inhibitorsSUN PHARMACEUTICAL IND INC·Filed 2024·Application pending·0 cites
- 1966US2025114367A1Method of treating hair loss disordersSUN PHARMACEUTICAL IND INC·Filed 2024·Application pending·0 cites
- 2064US2024425509A1Novel deuterated jak inhibitor and uses thereofSUN PHARMACEUTICAL IND INC·Filed 2024·Application pending·0 cites
- 2164US2025009884A1Topical compositions and methods for photodynamic therapySUN PHARMACEUTICAL IND INC·Filed 2022·Application pending·0 cites
- 2262US2025275979A1Treatment of hair loss disorders with deuterated jak inhibitorsSUN PHARMACEUTICAL IND INC·Filed 2025·Application pending·0 cites
- 2361US2025275977A1Dosage regimens for treatment with deuterated jak inhibitorsSUN PHARMACEUTICAL IND INC·Filed 2023·Application pending·0 cites
- 2459US2026021047A1Oral formulations of deuruxolitinibSUN PHARMACEUTICAL IND INC·Filed 2025·Application pending·0 cites
- 2558US2024368166A1Process for preparing enantiomerically enriched jak inhibitorsSUN PHARMACEUTICAL IND INC·Filed 2024·Application pending·0 cites
- 2658US2026027120A1Methods of treatment of jak inhibition responsive conditions with deuterated jak inhibitorsSUN PHARMACEUTICAL IND INC·Filed 2025·Application pending·0 cites
- 2757US2023390292A1Regimens for the treatment of hair loss disorders with deuterated jak inhibitorsSUN PHARMACEUTICAL IND INC·Filed 2021·Application pending·0 cites
- 2857US2026021098A1Methods of treatment of jak inhibition responsive conditions with deuterated jak inhibitorsSUN PHARMACEUTICAL IND INC·Filed 2025·Application pending·0 cites
- 2955US12325707B2Process for preparing enantiomerically enriched JAK inhibitorsSUN PHARMACEUTICAL IND INC·Filed 2020·Granted Jun 10, 2025·0 cites·19 claims
- 3055US2025326762A1Crystalline form of deuruxolitinibSUN PHARMACEUTICAL IND INC·Filed 2025·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →